Long-Term Follow-Up of a Child with EWSR1-BEND2 Fused Spinal Astroblastoma
Spinal astroblastoma is a rare and highly aggressive tumor affecting children and young adults with a high recurrence rate and thus far not well-defined prognosis. The molecular signature of astroblastoma needs to be further characterized to establish a treatment-relevant classification and to allow a better prognostication. Currently, gross-total resection combined with radiotherapy remains the mainstay of treatment for spinal astroblastoma.
Authors
- André O. von Bueren (ORCID: https://orcid.org/0000-0003-4197-6264)
- Axel Terrier
- Isabel Fernandes Arroteia (ORCID: https://orcid.org/0000-0002-5424-1198)
- Raphaël Guzman (ORCID: https://orcid.org/0000-0001-9620-0581)
- Stephan Frank (ORCID: https://orcid.org/0000-0001-6165-0187)
- Jehuda Soleman (ORCID: https://orcid.org/0000-0003-1900-9286)
- Marc Ansari (ORCID: https://orcid.org/0000-0002-9649-6498)
- Maria Licci (ORCID: https://orcid.org/0000-0002-2625-4151)
- Andréa Bartoli (ORCID: https://orcid.org/0000-0002-2965-8688)
- Jürgen Hench
- Pavlo Plavsky
Institutions
- University of Geneva (CH)
- University of Basel (CH)
- University Hospital of Basel (CH)
- University Hospital of Geneva (CH)
- University Children’s Hospital Basel (CH)
- Children's Specialized Hospital (US)
Publication Details
- Journal
- Pediatric Neurosurgery
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1159/000542050
- Citations
- 1
- Primary Topic
- Management of metastatic bone disease
- Type
- article
- Field-Weighted Citation Impact
- 0.57